{"transactions":[{"id":742972,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T00:11:44.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":65600,"derivative":{"exercise_price":7.25,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001364846-26-000003","document":"wk-form4_1781136701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000136484626000003/wk-form4_1781136701.xml","form_type":"4"}},{"id":967363,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-16T22:55:49.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":146020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2025 Equity Incentive Plan) through each applicable vesting date, 48,673 of the shares subject to the award will vest on December 12, 2026, 48,673 of the shares subject to the award will vest on December 12, 2027 and 48,674 of the shares subject to the award will vest on December 12, 2028, such that the award will be fully vested on December 12, 2028; provided that, notwithstanding the foregoing, any unvested shares subject to the award will fully vest immediately prior to a Change in Control (as defined in the 2025 Equity Incentive Plan), subject to the reporting person continuing to be a Service Provider through the date of such Change in Control."}],"balance_after":146020,"derivative":{"exercise_price":2.36,"expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":146020},"source":{"system":"sec-edgar","filing":"0001364846-25-000007","document":"wk-form4_1765925747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000136484625000007/wk-form4_1765925747.xml","form_type":"4"}},{"id":2039412,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-01T11:01:27.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct."}],"balance_after":500000,"derivative":{"exercise_price":0.837,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-23-003224","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223003224/ownership.xml","form_type":"4"}},{"id":2205918,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2022-07-20T01:42:46.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023."}],"balance_after":50000,"derivative":{"exercise_price":2.48,"expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-019871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019871/ownership.xml","form_type":"4"}},{"id":2205917,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2022-07-20T01:42:46.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.48,"exercise_date":"2022-07-15","expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-019871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019871/ownership.xml","form_type":"4"}},{"id":2546789,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true}}],"security":"Option to purchase Common Stock","published_at":"2021-10-07T18:47:17.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares vest on February 16, 2021, 2022, and 2023."}],"balance_after":50000,"derivative":{"exercise_price":6.33,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001654954-21-010887","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421010887/section16.xml","form_type":"4"}},{"id":2546788,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-07T18:47:17.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":347572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of shares of restricted stock (\"RSAs\"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022."}],"balance_after":352655,"source":{"system":"sec-edgar","filing":"0001654954-21-010887","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421010887/section16.xml","form_type":"4"}},{"id":2546787,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-07T18:47:17.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":441,"price":8.73,"value":3849.93,"ownership":{"direct":true},"balance_after":5083,"source":{"system":"sec-edgar","filing":"0001654954-21-010887","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421010887/section16.xml","form_type":"4"}},{"id":2546786,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-07T18:47:17.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":1374,"price":8.87,"value":12187.38,"ownership":{"direct":true},"balance_after":4642,"source":{"system":"sec-edgar","filing":"0001654954-21-010887","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421010887/section16.xml","form_type":"4"}},{"id":2546785,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-07T18:47:17.000Z","date":"2020-11-16","kind":"purchase","acquired":true,"shares":3268,"price":3.14,"value":10261.52,"ownership":{"direct":true},"balance_after":3268,"source":{"system":"sec-edgar","filing":"0001654954-21-010887","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421010887/section16.xml","form_type":"4"}},{"id":3105159,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T22:12:54.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which the remaining unvested portion shall vest), beginning on June 30, 2020 and ending on May 31, 2021, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.77,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000904454-20-000411","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364846/000090445420000411/edgar.xml","form_type":"4"}},{"id":3478558,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-26T01:40:51.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which the remaining unvested portion shall vest), beginning on 7/21/2019 and ending on 06/21/2020, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.81,"expiration_date":"2029-06-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-19-037503","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364846/000110465919037503/a4.xml","form_type":"4"}},{"id":3659896,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T21:58:19.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which the remaining unvested portion shall vest), beginning on 7/11/2018 and ending on 06/11/2019, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.59,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000904454-19-000227","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364846/000090445419000227/edgar.xml","form_type":"5"}},{"id":4280416,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":39628,"kind":"person","name":"Wendel Bruce","position":1,"cik":"0001364846","reported_name":"Wendel Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-15T20:22:06.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017."}],"balance_after":25000,"derivative":{"exercise_price":2.09,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-17-039560","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364846/000110465917039560/a4.xml","form_type":"4"}}]}